NKI

Amsterdam 1066 CX

0 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Colorectal Cancer (CRC), Gastric Cancer, Head and Neck Cancer, Lung Cancer, Mesothelioma, Metastatic Cancer, NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, Renal Cell Carcinoma (RCC), Solid Tumors

Studies at this site

• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors — Completed
• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) — Running, not enrolling